Order form [Credit Card Payment
] [Bank Transfer Payment]MTA, for use for not-for-profit academic purpose [Word
]Please visit Information of Request for Distribution.[link]
icon below as well as clone information before placing your order.
Expression vector of human IGF1R cDNA.
|
Other clones in our bank
External Database Human IGF1R Reference sequence |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
| Terms and conditions for distribution | The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested (Ishii, K. et al., J. Gene Med. 10 (6): 597-609, 2008; Tanaka, T. et al., Clin. Cancer Res. 12 (12): 3803-3813, 2006). In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. |
|---|---|
| Ordering | Order form [Credit Card Payment ] [Bank Transfer Payment]MTA, for use for not-for-profit academic purpose [Word ]Please visit Information of Request for Distribution.[link] |
[open/close]| 提供条件 | 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Ishii, K. et al., J. Gene Med. 10 (6): 597-609, 2008; Tanaka, T. et al., Clin. Cancer Res. 12 (12): 3803-3813, 2006)。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。 |
|---|---|
| 提供依頼 | 提供依頼書 [Word ]提供同意書 (MTA, 非営利学術目的用)[Word ]手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
| Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
|---|---|---|---|
| RDB07648 | pcDNA3.1(-)-hIGF1R | DNA solution |
icon below as well as clone information before placing your order.Materials & Methods section:
| The pcDNA3.1(-)-hIGF1R was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07648). |
Reference section:
| Ishii, K., Nakamura, K., Kawaguchi, S., Li, R., Hirai, S., Sakuragi, N., Wada, T., Kato, K., Yamashita, T., Hamada, H., Selective gene transfer into neurons via Na,K-ATPase beta1. Targeting gene transfer with monoclonal antibody and adenovirus vector. J. Gene Med., 10, 597-609 (2008). PMID 18383483. |
| Tanaka, T., Huang, J., Hirai, S., Kuroki, M., Kuroki, M., Watanabe, N., Tomihara, K., Kato, K., Hamada, H., arcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors. Clin. Cancer Res., 12, 3803-3813 (2006). PMID 16778108. |
Further references such as user reports and related articles (go to bottom)
Featured content
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
| Test sheet | RDB07648_B2Dsp1-1.pdf |
|---|
Nucleotide sequence of a portion of this resource (if available).
|
Primer: CMV_Forward (Pr0016) Region: CMV pro,insert5' Sequence file: RDB07648_B2Dsa.seq
|
|---|
|
>07648_07648_B2Ds_1_CMV_Forward_D02_04_ABI08.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNNCNNNANG CNNGTNCNGN GGGANGNCTN 61 NNNNNNCAGA GCTCTCTGGC TAACTAGAGA ACCCACTGCT TACTGGCTTA TCGAAATTAA 121 TACGACTCAC TATAGGGAGA CCCAAGCTGG CTAGCGTTTA AACGGGCCCT CTAGACTCGA 181 GCGGCCGCCA CTGTGCTGGA TATCTGCAGA ATTCGCCCTT TGAGAAAGGG AATTTCATCC 241 CAAATAAAAG GAATGAAGTC TGGCTCCGGA GGAGGGTCCC CGACCTCGCT GTGGGGGCTC 301 CTGTTTCTCT CCGCCGCGCT CTCGCTCTGG CCGACGAGTG GAGAAATCTG CGGGCCAGGC 361 ATCGACATCC GCAACGACTA TCAGCAGCTG AAGCGCCTGG AGAACTGCAC GGTGATCGAG 421 GGCTACCTCC ACATCCTGCT CATCTCCAAG GCCGAGGACT ACCGCAGCTA CCGCTTCCCC 481 AAGCTCACGG TCATTACCGA GTACTTGCTG CTGTTCCGAG TGGCTGGCCT CGAGAGCCTC 541 GGAGACCTCT TCCCCAACCT CACGGTCATC CGCGGCTGGA AACTCTTCTA CAACTACGCC 601 CTGGTCATCT TCGAGATGAC CAATCTCAAG GATATTGGGC TTTACAACCT GAGGAACATT 661 ACTCGGGGGG CCATCAGGAT TGAGAAAAAT GCTGACCTCT GTTACCTCTC CACTGTGGAC 721 TGGTCCCTGA TCCTGGATGC GGTGTCCAAT AACTACATTG TGGGGAATAA GCCCCCAAAG 781 GANNGTGGGG ANCTGTGTCC AGGGNNCATG GGAGGAGAAG CCGANGTGTG ANAAGANCNN 841 NNTCAACNAN TGAGTACAAC TACCGCTGCT GGACCANNAA CCGCTGCCAG AAAATGTGCC 901 CNAGCACGTG TGGGNAAGCN GGGCGTGCAC CGAGAACNAT GAGTGCTGNC NCCCCCGANT 961 GNCTGGGCNN CTGNNGCNCG CNTGANNNCN ACNNNGGCCT GNNNAGCNTG NCNNNNCTAC 1021 TNNNANNNCC GGNNNNNNGT NNNNNNNNNC NNNNNNNNCC NNNNCCNNCN NNNTTNNNNN 1081 GNNNNGGNNN NNNNNNN // |
|
Primer: bGH_rev3 (Pr0885) Region: insert 3' Sequence file: RDB07648_B2Dsb.seq
|
|
>07648_07648_B2Ds_1_bGH_rev3_F05_17_ABI24.ab1 1 NNNNNNNNNN NNNNNGGNNG NNGGNNNNNN ACNGATGGCT GGCAACTAGA AGGCACAGTC 61 GAGGCTGNTC NGCGGTTTAA ACTTAAGCTT GGTACCGAGC TCGGATCCAC TAGTCCAGTG 121 TGGTGGAATT CGCCCTTAAC ACTTGGGCTT CCCAGCTGGA CTTGTGGCAA TTATTTTTCC 181 GTTATGAAGC AGAGAGGAGA GAGAAAGGGA GAACAGGGAA GGACAGGGAC AGAGTGAGGA 241 GACTGGTTCT CAAGTGCTCT GTTGCTATTA AGTGTTGTCA TTAAGGTTCT TAAAGGCCCA 301 TGTCAGTTAA GGGTTTGGGC AGGGAATAAA AAGCTGCTTG CATATTGAAA AAAGGAACAT 361 CCCAAATGTG TTTTACTGCA GAGAAGCTGT CTCCCGCGGG CAGCAAGGGC AGTTCTGAAG 421 ATCCACTGAG GTACAGGAGG CTTGTGAATG GATTGTTAAA ACTCTCTCTC CCCCCCCACC 481 CCGCTGCGCG TGCGCACACG TTACTGTTTG CACAGATTCA GGATCCAAGG ATCAGCAGGT 541 CGAAGACTGG GGCAGCGGCA AGGCCCGCTC GTTCTTGCGG CCCCCGTTCA TGTGGGCGTA 601 AGGCTGTCTC TCGTCGAAGC TGGCGCGGAG GACCAGCACC CCAGGGCCGG GGCCGTTCTC 661 GGCCTTGTGT CCTGAGTGTC TGTCGGGCAG TGGCAGGGAG GACGAGGANG CCGANGGGTC 721 CAGGGGGACG CTCTCCATGT TCTCTGGCTC CAGGTCCAGC TCCTCCGGCT CGGGCAGCTT 781 GTTCTCCTCG CTGTAGTAGA ANGAGACCTC CCGGAAGCCA GGCTCCATCT CCTCTTTGAT 841 GCTGCTGANG NTCTCCAGGA ANGAANGCCT CATCTTGGGG TTATACTGNC AGCACATGCG 901 CATCANTTCA AACAGCATGT CNNNANAGTT GNCTGGNTTG TCCAGAANNN NGCCCTNNNT 961 GNNNAANCNN ANNNNNNGCN CNNNGGNNNN GCCCNNNNNN GNCNNNNNNG NNNNNNNNNG 1021 NNNNNNNNCN NNNNNNNNN // |
|
Primer: SV40pro_ori_F (Pr0731) Region: SV40 pro_ori,NeoR Sequence file: RDB07648_B2Dsc.seq
|
|
>07648_07648_B2Ds_1_SV40pro_ori_F_G05_20_ABI24.ab1 1 NNNNNNNNNN NNNNGNNGCC TCTGCCTCTG ANCTATTCNN GAAGTAGTGA GGAGGCTTTT 61 TTGGAGNCCT AGGCTTTTGC AAAAAGCTCC CGGGAGCTTG TATATCCATT TTCGGATCTG 121 ATCAAGAGAC AGGATGAGGA TCGTTTCGCA TGATTGAACA AGATGGATTG CACGCAGGTT 181 CTCCGGCCGC TTGGGTGGAG AGGCTATTCG GCTATGACTG GGCACAACAG ACAATCGGCT 241 GCTCTGATGC CGCCGTGTTC CGGCTGTCAG CGCAGGGGCG CCCGGTTCTT TTTGTCAAGA 301 CCGACCTGTC CGGTGCCCTG AATGAACTGC AGGACGAGGC AGCGCGGCTA TCGTGGCTGG 361 CCACGACGGG CGTTCCTTGC GCAGCTGTGC TCGACGTTGT CACTGAAGCG GGAAGGGACT 421 GGCTGCTATT GGGCGAAGTG CCGGGGCAGG ATCTCCTGTC ATCTCACCTT GCTCCTGCCG 481 AGAAAGTATC CATCATGGCT GATGCAATGC GGCGGCTGCA TACGCTTGAT CCGGCTACCT 541 GCCCATTCGA CCACCAAGCG AAACATCGCA TCGAGCGAGC ACGTACTCGG ATGGAAGCCG 601 GTCTTGTCGA TCAGGATGAT CTGGACGAAG AGCATCAGGG GCTCGCGCCA GCCGAACTGT 661 TCGCCAGGCT CAAGGCGCGC ATGCCCGACG GCGAGGATCT CGTCGTGACC CATGGCGATG 721 CCTGCTTGCC GAATATCATG GTGGAAAATG NCCGCTTTTC TGGATTCATC GACTGTGGCC 781 GGCTGGGTGT GNCGGANCGC TATCANGANA TAGCGTTGGC TACCCGTGAT ATTGCTGAAG 841 ANCTTGGCGG CGAATGGGCT GANCGCTTCC TCGNGCTTTA CNGTATCGCC GCTNCCGANN 901 CGCAGCGNAT CGCNNTCTAT CGCNNTCNNG ACGANNNNNN CNGANCNGNN NTNNGGGGNT 961 NNNNAATGNN NNANNNNNNN NNN // |
Please visit 
Sequencing and PCR primers for primer information.
Original, user report and related articles
| original | Ishii, K., Selective gene transfer into neurons via Na,K-ATPase beta1. Targeting gene transfer with monoclonal antibody and adenovirus vector. J. Gene Med., 10, 597-609 (2008). PMID 18383483. |
|---|---|
| original | Tanaka, T., arcinoembryonic antigen-targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors. Clin. Cancer Res., 12, 3803-3813 (2006). PMID 16778108. |
2024.03.26
HTML_filter_RDB_240326.pl